Literature DB >> 16830163

A high prevalence of methicillin-resistant Staphylococcus aureus among surgically drained soft-tissue infections in pediatric patients.

John Seal1, Loretto Glynn, Mindy Statter, Donald Liu.   

Abstract

Over the past decade, methicillin-resistant Staphylococcus aureus (MRSA) has emerged as a global problem, prompting extensive surveillance efforts. A previous study of S. aureus isolates at our institution revealed alarming increases in the prevalence of MRSA with no sign of plateau. However, evidence of MRSA in pediatric surgical patients remains largely anecdotal, as there are no published reports of institutional MRSA surveillance in the pediatric surgical literature. We conducted a retrospective review of incision and drainage (I and D) procedures at our institution from 1998 through 2004. All I and D procedures performed at the University of Chicago Children's Hospital were identified and the patients' charts reviewed for pertinent information. A total of 99 I and D procedures were performed during the study period, ranging from 5 in 1998 to 32 in 2004. Among cultures with positive growth, 52 (65.8%) were MRSA, 14 (17.7%) were methicillin-sensitive S. aureus, and 13 (16.5%) were miscellaneous species. The number of MRSA isolates increases from 2 in 1998 to 20 in 2004, the largest increase occurring during the last 3 years of the study. A large proportion of MRSA isolates were resistant to antimicrobials from other classes, with over 70% being resistant to both erythromycin and cefazolin. A majority of MRSA isolates (71.4%) were obtained from patients with no record of prior hospitalization. Our analysis confirms a high prevalence of MRSA among soft-tissue infections requiring surgical drainage. In addition, a majority of MRSA isolates were resistant to multiple antimicrobials and were isolated from children without a previous documented exposure to the hospital milieu. Thus, pediatric surgeons should be aware of MRSA prevalence and resistance patterns in the local communities.

Entities:  

Mesh:

Year:  2006        PMID: 16830163     DOI: 10.1007/s00383-006-1684-x

Source DB:  PubMed          Journal:  Pediatr Surg Int        ISSN: 0179-0358            Impact factor:   1.827


  15 in total

1.  Methicillin-resistant Staphylococcus aureus in the hospitals of central Greece.

Authors:  E Petinaki; V Miriagou; L S Tzouvelekis; S Pournaras; F Hatzi; F Kontos; M Maniati; A N Maniatis
Journal:  Int J Antimicrob Agents       Date:  2001-07       Impact factor: 5.283

2.  Changing pattern of antibiotic resistance in methicillin-resistant Staphylococcus aureus from German hospitals.

Authors:  W Witte; C Braulke; C Cuny; D Heuck; M Kresken
Journal:  Infect Control Hosp Epidemiol       Date:  2001-11       Impact factor: 3.254

3.  The population impact of MRSA in a country: the national survey of MRSA in Wales, 1997.

Authors:  M Morgan; D Evans-Williams; R Salmon; I Hosein; D N Looker; A Howard
Journal:  J Hosp Infect       Date:  2000-03       Impact factor: 3.926

4.  Vancomycin-resistant Staphylococcus aureus--Pennsylvania, 2002.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2002-10-11       Impact factor: 17.586

5.  Community-acquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk.

Authors:  B C Herold; L C Immergluck; M C Maranan; D S Lauderdale; R E Gaskin; S Boyle-Vavra; C D Leitch; R S Daum
Journal:  JAMA       Date:  1998-02-25       Impact factor: 56.272

6.  Methicillin resistance among Trinidadian isolates of community and hospital strains of Staphylococcus aureus and their patterns of resistance to non-beta-lactam antibiotics.

Authors:  F A Orrett
Journal:  Jpn J Infect Dis       Date:  1999-12       Impact factor: 1.362

7.  The evolution of methicillin-resistant Staphylococcus aureus in Canadian hospitals: 5 years of national surveillance.

Authors:  A E Simor; M Ofner-Agostini; E Bryce; K Green; A McGeer; M Mulvey; S Paton
Journal:  CMAJ       Date:  2001-07-10       Impact factor: 8.262

8.  Methicillin-resistant Staphylococcus aureus in Western Australia, 1983-1992.

Authors:  T V Riley; I L Rouse
Journal:  J Hosp Infect       Date:  1995-03       Impact factor: 3.926

Review 9.  Evolving antimicrobial chemotherapy for Staphylococcus aureus infections: Our backs to the wall.

Authors:  R S Daum; J B Seal
Journal:  Crit Care Med       Date:  2001-04       Impact factor: 7.598

10.  Epidemiology and susceptibility of 3,051 Staphylococcus aureus isolates from 25 university hospitals participating in the European SENTRY study.

Authors:  A C Fluit; C L Wielders; J Verhoef; F J Schmitz
Journal:  J Clin Microbiol       Date:  2001-10       Impact factor: 5.948

View more
  2 in total

1.  A pediatric acute wound service: a novel approach in wound management.

Authors:  B T Bucher; J Seigel; E Rosenblum; C Nesslein; S Keswani; R P Foglia; P A Dillon; B W Warner; Martin S Keller
Journal:  J Pediatr Surg       Date:  2010-01       Impact factor: 2.545

2.  Induction of multiple matrix metalloproteinases in human dermal and synovial fibroblasts by Staphylococcus aureus: implications in the pathogenesis of septic arthritis and other soft tissue infections.

Authors:  Siva Kanangat; Arnold Postlethwaite; Karen Hasty; Andrew Kang; Mark Smeltzer; Whitney Appling; Dennis Schaberg
Journal:  Arthritis Res Ther       Date:  2006       Impact factor: 5.156

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.